Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan Yoon Cheah

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Haematologica|August 8, 2015
Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphomaNathan H Fowler, Loretta J Nastoupil, Frederick B Hagemeister, et al.
Annals of Hematology|January 9, 2019
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?Dai Chihara, Yasuhiro Oki, Michelle A Fanale, et al.
Oncotarget|July 11, 2018
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysisDai Chihara, Nathan H Fowler, Yasuhiro Oki, et al.
The Lancet. Haematology|December 22, 2015
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised studyChan Yoon Cheah, David Belada, Michelle A Fanale, et al.
Plastic and Reconstructive Surgery|February 19, 2016
Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell LymphomaHonghua Hu, Khalid Johani, Ahmad Almatroudi, et al.
British Journal of Haematology|June 18, 2019
Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinationsDoen Ming Ong, Michael Ashby, Andrew Grigg, et al.
Cancer Medicine|December 7, 2019
An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvementAndrew J Sunderland, Raphael E Steiner, Musa Al Zahrani, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
British Journal of Haematology|June 26, 2019
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma AllianceJoel C Wight, Mimi Yue, Colm Keane, et al.
Leukemia & Lymphoma|February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases RegistryDiva Baggio, Cameron Wellard, Eliza Chung, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Haematologica|August 8, 2015
Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphomaNathan H Fowler, Loretta J Nastoupil, Frederick B Hagemeister, et al.
Annals of Hematology|January 9, 2019
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?Dai Chihara, Yasuhiro Oki, Michelle A Fanale, et al.
Oncotarget|July 11, 2018
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysisDai Chihara, Nathan H Fowler, Yasuhiro Oki, et al.
The Lancet. Haematology|December 22, 2015
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised studyChan Yoon Cheah, David Belada, Michelle A Fanale, et al.
Plastic and Reconstructive Surgery|February 19, 2016
Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell LymphomaHonghua Hu, Khalid Johani, Ahmad Almatroudi, et al.
British Journal of Haematology|June 18, 2019
Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinationsDoen Ming Ong, Michael Ashby, Andrew Grigg, et al.
Cancer Medicine|December 7, 2019
An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvementAndrew J Sunderland, Raphael E Steiner, Musa Al Zahrani, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
British Journal of Haematology|June 26, 2019
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma AllianceJoel C Wight, Mimi Yue, Colm Keane, et al.
Leukemia & Lymphoma|February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases RegistryDiva Baggio, Cameron Wellard, Eliza Chung, et al.
Pageof 7